"Human papillomavirus 18" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type of human papillomavirus especially associated with malignant tumors of the genital and RESPIRATORY MUCOSA.
| Descriptor ID |
D052161
|
| MeSH Number(s) |
B04.280.210.655.050.618 B04.613.204.655.050.618
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Human papillomavirus 18".
Below are MeSH descriptors whose meaning is more specific than "Human papillomavirus 18".
This graph shows the total number of publications written about "Human papillomavirus 18" by people in this website by year, and whether "Human papillomavirus 18" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 3 | 3 |
| 2024 | 0 | 1 | 1 |
| 2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Human papillomavirus 18" by people in Profiles.
-
Extraction-free RT-RPA assay for detection of HPV16, HPV18, and HPV45 mRNA expression. Sci Rep. 2025 Aug 19; 15(1):30450.
-
A novel method for semi-quantitative detection of HPV16 and HPV18 mRNA with a low-cost, open-source fluorimeter. Anal Bioanal Chem. 2025 Apr; 417(9):1765-1778.
-
Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status. Int J Cancer. 2024 Jul 15; 155(2):251-260.
-
Single-tube four-target lateral flow assay detects human papillomavirus types associated with majority of cervical cancers. Anal Biochem. 2024 May; 688:115480.
-
A novel tailed primer nucleic acid test for detection of HPV 16, 18 and 45 DNA at the point of care. Sci Rep. 2023 11 21; 13(1):20397.
-
Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers. Oncologist. 2023 07 05; 28(7):618-623.
-
An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings. Sci Transl Med. 2023 06 21; 15(701):eabn4768.
-
Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2023 02 01; 29(3):560-570.
-
Usefulness of high-risk HPV early oncoprotein (E6 and E7) serological markers in the detection of cervical cancer: A systematic review and meta-analysis. J Med Virol. 2023 01; 95(1):e27900.
-
Social networks, high-risk anal HPV and coinfection with HIV in young sexual minority men. Sex Transm Infect. 2022 12; 98(8):557-563.